Vikas K Gupta (Vikas Gupta)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 38

Top Topics

Venous Thromboembolism

Acute Lymphoblastic Leukemia

Ejection Fraction

Tyrosine Kinase

Top Venues

American journal of hematology

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G Atenafu, Vikas K Gupta
Screening for Signs of Portal Hypertension by Esophagogastroduodenoscopy in Patients with BCR-ABL Negative Myeloproliferative Neoplasms. American journal of hematology (2023)
Aniket Bankar, Wing C Chan, Ning Liu, Matthew C Cheung, Shabbir Mh Alibhai, Vikas K Gupta
Prevalence and Association of Frailty with Clinical Outcomes in Myeloproliferative Neoplasms: A Population-Based Study. Blood advances (2023)
Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G Atenafu, Vikas K Gupta
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms. American journal of hematology (2023)
James T England, Eshetu G Atenafu, James A Kennedy, Burhan Goraya, Verna Cheung, Taylor Nye, Karine Gauthier, Marta B Davidson, Aniket Bankar, Hassan Sibai, Dawn Maze, Auro Viswabandya, Vikas K Gupta
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first-line JAK-inhibitor. American journal of hematology (2023)
Dawn Maze, Murat O Arcasoy, Ryan Henrie, Sonia Cerquozzi, Rammurti Kamble, Samer Al-Hadidi, Abdulraheem Yacoub, Anurag K Singh, Mahmoud Elsawy, Shireen Sirhan, Elliot Smith, Curtis Marcoux, Auro Viswabandya, Andrew Daly, Hassan Sibai, Caroline McNamara, Yuliang Shi, Wei Xu, Katherine Lajkosz, Lynda Foltz, Vikas K Gupta
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study. Bone marrow transplantation (2023)
James T England, Eshetu G Atenafu, James A Kennedy, Burhan Goraya, Verna Cheung, Taylor Nye, Karine Gauthier, Marta B Davidson, Aniket Bankar, Hassan Sibai, Dawn Maze, Auro Viswabandya, Vikas K Gupta
Comparison of Clinical Outcomes Between Transplant and Non-Transplant Therapies in Myelofibrosis Following Failure of First-line JAK-Inhibitor. American journal of hematology (2023)
John O Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K Rampal, Adam J Mead, Gabriella Hobbs, Joseph M Scandura, Moshe Talpaz, Nikki Granacher, Tim C P Somervaille, Ronald Hoffman, Marielle J Wondergem, Mohamed E Salama, Gozde Colak, Jike Cui, Jean-Jacques Kiladjian, Alessandro Maria Maria Vannucchi, Srdan Verstovsek, Natalia Curto-García, Claire N Harrison, Vikas K Gupta
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Maryam Rafati, Derek W Brown, Weiyin Zhou, Kristine M Jones, Wen Luo, Andrew St Martin, Youjin Wang, Meilun He, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas K Gupta, Stephanie J Lee, Yung-Tsi Bolon, Stephen J Chanock, Mitchell J Machiela, Wael Saber, Shahinaz M Gadalla
JAK2V617F Mutation and Associated Chromosomal Alterations in Primary and Secondary Myelofibrosis and Post-HCT Outcomes. Blood advances (2023)
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Carlos Hernández-Boluda, Sergio A Giralt, Jeanne M Palmer, Robert Peter Gale, Zachariah DeFilipp, David Marks, Marjolein W M van der Poel, Leo F Verdonck, Minoo Battiwalla, Miguel A Díaz, Vikas K Gupta, Haris Ali, Mark R Litzow, Hillard M Lazarus, Usama Gergis, Asad Bashey, Jane L Liesveld, Shahrukh K. Hashmi, Jeffrey J Pu, Amer Beitinjaneh, Christopher N Bredeson, David A Rizzieri, Bipin N Savani, Muhammad Bilal Abid, Siddhartha Ganguly, Vaibhav Agrawal, Vera Ulrike Bacher, Baldeep Wirk, Tania Jain, Corey S Cutler, Mahmoud Aljurf, Tamila Kindwall-Keller, Mohamed A Kharfan-Dabaja, Gerhard C Hildebrandt, Attaphol Pawarode, Melhem M Solh, Jean A Yared, Michael R Grunwald, Sunita Nathan, Taiga Nishihori, Sachiko Seo, Bart L Scott, Ryotaro Nakamura, Betul Oran, Tomasz Czerw, Ibrahim Yakoub Agha, Wael Saber
A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis. Blood advances (2023)
Francesca Palandri, Haifa Kathrin Al-Ali, Paola Guglielmelli, Mike W Zuurman, Rajendra Sarkar, Vikas K Gupta
Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study. Cancers 15 (10) (2023)
Tania Jain, Hua-Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Sarah Wall, Lukasz P Gondek, Asad Bashey, Alla Keyzner, Roni Tamari, Michael R Grunwald, Sameem Abedin, Kalyan Nadiminti, Madiha Iqbal, Aaron T Gerds, Auro Viswabandya, Shannon McCurdy, Monzr M Al Malki, Ravi Varadhan, Haris Ali, Vikas K Gupta, Richard John Jones, Salman Otoukesh
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration. Research square (2023)
Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G Atenafu, Vikas K Gupta
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms. American journal of hematology 98 (4) (2023)
Stephen T Oh, Ruben A Mesa, Claire N Harrison, Prithviraj Bose, Aaron T Gerds, Vikas K Gupta, Bart L Scott, Jean-Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah A Buckley, Shanthakumar Tyavanagimatt, Bryan G Harder, Karisse Roman-Torres, Jennifer Smith, Adam R Craig, John O Mascarenhas, Srdan Verstovsek
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis. Blood advances (2023)
Srdan Verstovsek, Ruben A Mesa, Vikas K Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy, Stephen T Oh, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire N Harrison
Momelotinib Long-Term Safety and Survival in Myelofibrosis: Integrated Analysis of Phase 3 Randomized-Controlled Trials. Blood advances (2023)
Vikas K Gupta, John O Mascarenhas, Marina Kremyanskaya, Raajit K Rampal, Moshe Talpaz, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Srdan Verstovsek, Gozde Colak, Debarshi Dey, Claire N Harrison
Matching-adjusted indirect comparison of pelabresib/ruxolitinib combination vs JAKi monotherapy in myelofibrosis. Blood advances (2023)
Ruiqi Chen, Eshetu G Atenafu, Jack Seki, Xing Liu, Steven Chan, Vikas K Gupta, Dawn Maze, Andre C Shuh, Mark D Minden, Karen Yee, Aaron D Schimmer, Hassan Sibai
Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L-ASP: A retrospective analysis with an ASP-based protocol in adult patients with acute lymphoblastic leukaemia. British journal of haematology (2023)
Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G Atenafu, Vikas K Gupta
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms. American journal of hematology 98 (4) (2023)
Fabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, Ilias Ettayebi, Helen Loo Yau, Tiago Silva Medina, Sajid A Marhon, Felipe Campos de Almeida, Thiago Mantello Bianco, Andrea G F Arruda, Rebecca Devlin, Lorena Lobo de Figueiredo-Pontes, Fernando Chahud, Maira da Costa Cacemiro, Mark D Minden, Vikas K Gupta, Daniel D De Carvalho
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia. British journal of haematology (2023)
Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G Atenafu, Vikas K Gupta
Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR-ABL negative myeloproliferative neoplasms. American journal of hematology 98 (4) (2023)
Rabab Taha, Sagar Kothari, Farid Foroutan, Melissa Randy Gitman, Vikas K Gupta, Tram Nguyen, Coleman Rotstein
Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center. Current oncology (Toronto, Ont.) 29 (12) (2022)
Derek W Brown, Weiyin Zhou, Youjin Wang, Kristine Jones, Wen Luo, Casey L Dagnall, Kedest Teshome, Alyssa Klein, Tongwu Zhang, Shu-Hong Lin, Olivia W Lee, Sairah Khan, Jacqueline B Vo, Amy Hutchinson, Jia Liu, Jiahui Wang, Bin Zhu, Belynda D Hicks, Andrew St Martin, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas K Gupta, Stephanie J Lee, Neal D Freedman, Meredith Yeager, Stephen J Chanock, Sharon A Savage, Wael Saber, Shahinaz M Gadalla, Mitchell J Machiela
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis. Nature communications 13 (1) (2022)
Dawn Maze, Iyad Arusi, Vikas K Gupta, Eshetu G Atenafu, Ann Kinga Malinowski, Nadine Shehata
Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms. EJHaem 4 (1) (2022)
Heidi E Kosiorek, Robyn M Scherber, Holly L Geyer, Srdan Verstovsek, Blake T Langlais, Gina L Mazza, Jason Gotlib, Vikas K Gupta, Leslie J Padrnos, Jeanne M Palmer, Angela Fleischman, Ruben A Mesa, Amylou C Dueck
Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)-I study. British journal of haematology 198 (6) (2022)
Naveen Pemmaraju, Hagop M Kantarjian, Kendra L Sweet, Eunice S Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Y Konopleva, Arthur E Frankel, Vikas K Gupta, Ruben A Mesa, Matthew L Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James R Mason, Maria Teresa García-Romero, Norma C Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland Bruno Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K Rampal, Marcos de Lima, James M Foran, Amir T Fathi, Aric Hall, Meagan A Jacoby, Jeffrey E Lancet, Gabriel N Mannis, Anthony S Stein, Alice S Mims, David A Rizzieri, Rebecca L Olin, Alexander E Perl, Gary J Schiller, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew J Wieduwilt, Naval G Daver, Farhad Ravandi, Sumithira Vasu, Monica L Guzman, Gail J Roboz, Joseph D Khoury, Muzaffar H Qazilbash, Leomar Y Ballester, Branko Cuglievan, Yazan F Madanat, Mohamed A Kharfan-Dabaja, Anna B Pawlowska, Justin Taylor, Martin S Tallman, Prajwal Dhakal, Andrew A Lane
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need. Blood (2022)
Ruben A Mesa, Claire Harrison, Stephen T Oh, Aaron T Gerds, Vikas K Gupta, John Catalano, Francisco Cervantes, Timothy Devos, Marek Hus, Jean-Jacques Kiladjian, Ewa Lech-Maranda, Donal P McLornan, Alessandro M Vannucchi, Uwe Platzbecker, Mei Huang, Bryan Strouse, Barbara J Klencke, Srdan Verstovsek
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis. Leukemia 36 (9) (2022)
Ibrahim Al Nabhani, Claire Andrews, Jad Sibai, Eshetu G Atenafu, Taylor Young, Steven M Chan, Vikas K Gupta, Dawn Maze, Aaron D Schimmer, Andre C Schuh, Karen Yee, Hassan Sibai
Safety of re-challenging adults with acute lymphoblastic leukemia with PEG-asparaginase-induced severe hypertriglyceridemia when treated with a pediatric-inspired regimen. EJHaem 4 (1) (2022)
Rabab Taha, Sagar Kothari, Farid Foroutan, Melissa Randy Gitman, Vikas K Gupta, Tram Nguyen, Coleman Rotstein
Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center. Current oncology (Toronto, Ont.) 29 (12) (2022)
Rabab Taha, Sagar Kothari, Farid Foroutan, Melissa Randy Gitman, Vikas K Gupta, Tram Nguyen, Coleman Rotstein
Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center. Current oncology (Toronto, Ont.) 29 (12) (2022)
Rabab Taha, Sagar Kothari, Farid Foroutan, Melissa Randy Gitman, Vikas K Gupta, Tram Nguyen, Coleman Rotstein
Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center. Current oncology (Toronto, Ont.) 29 (12) (2022)
Dawn Maze, Iyad Arusi, Vikas K Gupta, Eshetu G Atenafu, Ann Kinga Malinowski, Nadine Shehata
Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms. EJHaem 4 (1) (2022)
James T England, Caroline J McNamara, James A Kennedy, Jose-Mario Capo-Chichi, Jingyue Huang, Andrea Arruda, Taylor Nye, Verna Cheung, Jaime O Claudio, Dawn Maze, Hassan Sibai, Anne Tierens, Hubert Tsui, Aniket Bankar, Wei Xu, Tracy L Stockley, Vikas K Gupta
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort. Leukemia 36 (6) (2022)
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit K Rampal, Srdan Verstovsek, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben A Mesa, Andrew T Kuykendall, Alessandro Maria Maria Vannucchi, Francesca Palandri, Sebastian Grosicki, Timothy Devos, Eric Jourdan, Marielle J Wondergem, Haifa Kathrin Al-Ali, Veronika Buxhofer-Ausch, Alberto Álvarez-Larrán, Andrea Patriarca, Marina Kremyanskaya, Adam J Mead, Sanjay Akhani, Yuri Sheikine, Gozde Colak, John O Mascarenhas
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis. Future oncology (London, England) 18 (27) (2022)
John O Mascarenhas, Francesco Passamonti, Kate Burbury, Tarec Christoffer El-Galaly, Aaron T Gerds, Vikas K Gupta, Brian Higgins, Kathrin Wonde, Candice Jamois, Bruno Kovic, Ling-Yuh Huw, Sudhakar Katakam, Margherita Maffioli, Ruben A Mesa, Jeanne Palmer, Marta Bellini, David Morrall Ross, Alessandro Maria Maria Vannucchi, Abdulraheem Yacoub
The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. Blood advances 6 (4) (2022)
Rabab Taha, Sagar Kothari, Farid Foroutan, Melissa Randy Gitman, Vikas K Gupta, Tram Nguyen, Coleman Rotstein
Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center. Current oncology (Toronto, Ont.) 29 (12) (2022)
Ibrahim Al Nabhani, Claire Andrews, Jad Sibai, Eshetu G Atenafu, Taylor Young, Steven M Chan, Vikas K Gupta, Dawn Maze, Aaron D Schimmer, Andre C Schuh, Karen Yee, Hassan Sibai
Safety of re-challenging adults with acute lymphoblastic leukemia with PEG-asparaginase-induced severe hypertriglyceridemia when treated with a pediatric-inspired regimen. EJHaem 4 (1) (2022)
Aniket Bankar, Shabbir Alibhai, Elliot Smith, Dongyang Yang, Sarah Malik, Verna Cheung, Nancy Siddiq, Jaime Claudio, Andrea Arruda, Hubert Tsui, Jose-Mario Capo-Chichi, James A Kennedy, Caroline McNamara, Hassan Sibai, Dawn Maze, Wei Xu, Vikas K Gupta
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study. British journal of haematology 194 (3) (2021)
James T England, Vikas K Gupta
Hydroxycarbamide-related cutaneous ulcer complicated by osteomyelitis. EJHaem 2 (4) (2021)
Srdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, Martin Ellis, Maria Laura Fox, Yeow T Goh, Vikas K Gupta, Claire Harrison, Jean-Jacques Kiladjian, Mihaela C Lazaroiu, Adam J Mead, Donal McLornan, Mary Frances Frances McMullin, Stephen T Oh, Andrew Charles Perkins, Uwe Platzbecker, Christof Scheid, Alessandro Maria Maria Vannucchi, Sung-Soo Yoon, Mark M Kowalski, Ruben A Mesa
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic. Future oncology (London, England) 17 (12) (2021)